about
Chronic pneumonia with Pseudomonas aeruginosa and impaired alveolar fluid clearanceA composite score combining procalcitonin, C-reactive protein and temperature has a high positive predictive value for the diagnosis of intensive care-acquired infectionsRole of small GTPases and alphavbeta5 integrin in Pseudomonas aeruginosa-induced increase in lung endothelial permeabilityDistinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?Early norepinephrine resuscitation of life-threatening hypotensive septic shock: it can do the job, but at what cost?Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.Monitoring in the intensive care.Tracheal reconstruction with a composite graft: fascial flap-wrapped allogenic aorta with external cartilage-ring support.Vaginal Mucosal Homeostatic Response May Determine Pregnancy Outcome in Women With Bacterial Vaginosis: A Pilot StudyMonocyte deactivation in neutropenic acute respiratory distress syndrome patients treated with granulocyte colony-stimulating factorResidual rates of mortality in patients with severe sepsis: a fatality or a new challenge?Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal responseCandida albicans and Pseudomonas aeruginosa interactions: more than an opportunistic criminal association?Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model.Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia.Hospital-acquired pneumonia in critically ill patients: mortality risk stratification upon onset.Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: haemostasis parameters of a randomized controlled open labelled trial.Methodology to automatically detect abnormal values of vital parameters in anesthesia time-series: Proposal for an adaptable algorithm.Proteomic analysis of undiluted lung epithelial lining fluid.Chronic post-thyroidectomy pain: Incidence, typology, and risk factors.Risk factors for Pneumocystis pneumonia after the first 6 months following renal transplantation.Postoperative ischemic bronchitis after lymph node dissection and primary lung cancer resection.Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system.Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways.Protective role of murine norovirus against Pseudomonas aeruginosa acute pneumonia.Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection.The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients.The human NAIP-NLRC4-inflammasome senses the Pseudomonas aeruginosa T3SS inner-rod protein.Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases.Timing of RRT initiation in critically-ill patients: time for precision medicine.Identification of sexually transmitted bacteria in tubo-ovarian abscesses through nucleic acid amplification.Sevoflurane pre- and post-conditioning protect the brain via the mitochondrial K ATP channel.Promises and limitations of the bronchoscopic microsampling probe.Neutrophils in sepsis: battle of the bands.Immune tolerance of epithelium-denuded-cryopreserved tracheal allograft.Gabapentin attenuates late but not early postoperative pain after thyroidectomy with superficial cervical plexus block.Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa.Using urea as an endogenous marker of bronchoalveolar lavage dilution.
P50
Q24796711-6A909D12-6308-411C-83E5-D2CFF634752CQ34645087-96553267-264D-46CD-9256-2F8319E8438EQ34808927-0C22763A-952E-4F24-B306-297B16424FACQ35097505-07F4BF19-A08A-424B-AF18-5C6E241FA6C6Q35561422-A80782DD-9F6D-411B-B2E7-352F038C26A7Q35770922-5111FA2F-3C54-49D9-89DD-750ED813A22AQ36071762-C300F3E4-4BF1-44E7-ADE5-19334DF95CDBQ36206529-5F1C415B-F7C8-4462-ADAF-06B4B64FF852Q36470578-C6320D11-7160-42DD-8F42-84DBAF2FD2C1Q36566948-EA4B3C7E-FAC0-4CE8-9187-E8A0E341BF71Q36641962-37503A56-EC59-49F3-8E7B-B0E31AF5CEB9Q37355631-677A81A2-226B-4915-905F-ECC8B8A7FBC2Q37548220-7B5E023C-3C4E-48F9-A388-E6D00AF2B5ABQ38102364-832B70CB-477A-429E-9B88-7F1FACF443E3Q39189333-14ED35C6-11FE-414F-8FDD-6C25859B13DDQ39661220-4424F3DA-BAD4-46F0-943C-C427ABE53306Q39686713-CACD1A8D-6AAD-4731-8784-EC94D354EB91Q39828604-7127355C-1812-4C4F-992B-3269600C7233Q40053630-0468EE72-A964-4BA4-8324-E6BCA1A17B6EQ40062731-69AD75E5-A843-47B0-B784-DA1D58259127Q40063607-BB940BFA-FE5C-48C3-9244-CA24C86852E9Q40174669-E9899D98-CE39-4EE4-BA17-FFB8AE5C6041Q40336482-53FF9393-6D1B-40AC-9BFE-6726BA66301AQ40406147-B958E1B1-FA60-42F1-A375-DB7C7E79D59AQ40797243-89E21395-021C-4239-BE29-C54A650A0206Q41016091-80129719-4F6F-4F42-9565-C8BA56F45309Q41650972-F908DCCE-D382-48A5-90B2-F6D9C0FFDB08Q41871651-B34C722A-7136-487D-BFB1-16EE06768874Q41989592-9656F8FD-C3FC-428E-8AC5-2160C72A160FQ42203086-1936EF21-9CBF-41EE-923B-D1D49815F781Q42369325-85D08DC3-7968-4372-82FD-2D30BD0E3DA0Q42737580-302E7977-9FA8-499C-869D-32076E446242Q43189614-70D5E7B4-F9AA-4F5D-A17F-24C2BE2E9E65Q45080963-A84B85AA-88F1-4B43-AD28-0C4C5158627EQ45976491-B5DB11D9-F28B-4550-8E41-EF8249A7B0C0Q46285331-141FC161-CB79-40C9-943A-4F3B0E181F6AQ46309596-C50EF1A6-3319-4686-8F89-DB029A57B163Q46531853-B1CD7223-E251-4036-84C1-B3C233FD8748Q46581710-BFE0EA31-0146-4CD1-8BF4-908969326848Q46691632-89B70DA6-FD5B-4C37-85B8-B494A5B64806
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eric Kipnis
@ast
Eric Kipnis
@en
Eric Kipnis
@es
Eric Kipnis
@nl
Eric Kipnis
@sl
type
label
Eric Kipnis
@ast
Eric Kipnis
@en
Eric Kipnis
@es
Eric Kipnis
@nl
Eric Kipnis
@sl
prefLabel
Eric Kipnis
@ast
Eric Kipnis
@en
Eric Kipnis
@es
Eric Kipnis
@nl
Eric Kipnis
@sl
P1053
C-6286-2016
P106
P1153
55919191300
6506313040
P21
P2798
P31
P496
0000-0001-8887-7330